InvestorsObserver
×
News Home

Is Genfit SA (GNFT) the Top Pick in the Biotechnology Industry?

Tuesday, February 16, 2021 11:35 AM | InvestorsObserver Analysts

Mentioned in this article

Is Genfit SA (GNFT) the Top Pick in the Biotechnology Industry?

A rating of 43 puts Genfit SA (GNFT) near the middle of the Biotechnology industry according to InvestorsObserver. Genfit SA's score of 43 means it scores higher than 43% of stocks in the industry. Genfit SA also received an overall rating of 45, putting it above 45% of all stocks. Biotechnology is ranked 19 out of the 148 industries.

Overall Score - 45
GNFT has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on GNFT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 45 means the stock is more attractive than 45 percent of stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Genfit SA Stock Today?

Genfit SA (GNFT) stock is trading at $5.62 as of 11:28 AM on Tuesday, Feb 16, a rise of $0.12, or 2.18% from the previous closing price of $5.50. The stock has traded between $5.51 and $5.65 so far today. Volume today is below average. So far 198,584 shares have traded compared to average volume of 403,542 shares.

Click Here to get the full Stock Score Report on Genfit SA (GNFT) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App